Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-28

FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) from Chattem, Inc., related to its use in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Children's Allegra Allergy (Fexofenadine hydrochloride)

Snippet

SUPPL AP for CHILDRENS ALLEGRA ALLERGY (FEXOFENADINE HYDROCHLORIDE)